Wx. Ma et al., Improved immnunophenotyping of lymphocytes in bronchoalveolar lavage fluid(BALF) by flow cytometry, CLIN CHIM A, 313(1-2), 2001, pp. 133-138
Background: The immnunophenotyping of lymphocytes in bronchoalveolar lavage
fluid (BALF) is of particular importance in the differential diagnosis of
interstitial lung disorders. The standard method of lymphocyte phenotyping
is peroxidase-anti-peroxidase technique (PAP). However, it was time-consumi
ng and experience-dependent. Flow cytometric (FCM) analysis of BALF lymphoc
ytes was introduced to overcome these disadvantages. Unfortunately, when th
e number of cells counted was small, FCM could not distinguish lymphocytes
from other cells and particles in BALF by light scattering. Methods: We est
ablished a tri-color flow cytometric approach to phenotyping of lymphocytes
in BALF. FITC-CD45/PE-CD14 antibodies were used to gate lymphocytes and ex
clude other contamination. Propidium iodide (PI) was introduced to distingu
ish lymphocytes from debris. Forty-three BALF species were tested by flow c
ytometer as well as peripheral blood as a control group by conventional PAP
method. Results: The variation of FCM (CV < 1.0%) was much lower that that
of PAP method (CV > 9.8%). Meanwhile, we found that BALF had more clinical
significance than peripheral blood in T subset analysis (p < 0.01). There
were characteristic changes in some lung diseases. Both CD3 and CD4 were si
gnificantly increased with decreasing CD8 in sarcoidosis (n = 14). Idiopath
ic pulmonary fibrosis (n = 16) demonstrated the reverse tendency: CD8 rose
but both CD3 and CD4 dropped. As for lung cancer (n = 7), CD3 was normal bu
t the CD4/CD8 ratio declined. Tuberculosis of the lungs (n = 6) showed a no
rmal CD3, CD4 and CD8. Conclusions: The high precision and reliability of t
ri-color flow cytometric approach to phenotyping of lymphocytes in BALF sug
gested that it should be used as a routine test, especially of BALE, which
was often contaminated by inorganic particles. (C) 2001 Elsevier Science B.
V. All rights reserved.